Advanced search
Publication Cover
Modern Rheumatology Volume 30, 2020 - Issue 1
Journal homepage
6,692
Views
66
CrossRef citations to date
0
Altmetric
Review Articles

A large observational cohort study of rheumatoid arthritis, IORRA: Providing context for today’s treatment options

Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; ;Institute of Rheumatology, Sanno Medical Center, Tokyo, Japan; Correspondence[email protected] [email protected]
,
Eiichi TanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan;
,
Ayako NakajimaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; ;Center for Rheumatic Diseases, Mie University Hospital, Tsu, Japan;
,
Takefumi FuruyaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan;
,
Katsunori IkariInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan;
,
Atsuo TaniguchiInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan;
,
Eisuke InoueInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; ;Division of Medical Informatics, St. Marianna University School of Medicine, Kawasaki, Japan
&
Masayoshi HarigaiInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan;
show all
Pages 1-6 | Received 18 Jul 2019, Accepted 09 Aug 2019, Published online: 01 Oct 2019

Citations (66)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Pedro Santos-Moreno, Gabriel-Santiago Rodríguez-Vargas, Susan Martínez, Linda Ibatá, Laura Villarreal-Peralta, Anggie Aza-Cañon, Manuel Rivero, Pedro Rodriguez & Adriana Rojas-Villarraga. (2022) Better Clinical Results in Rheumatoid Arthritis Patients Treated Under a Multidisciplinary Care Model When Compared with a National Rheumatoid Arthritis Registry. Open Access Rheumatology: Research and Reviews 14, pages 269-280.
Read now
Ryu Watanabe, Motomu Hashimoto, Koichi Murata, Kosaku Murakami, Masao Tanaka, Koichiro Ohmura, Hiromu Ito & Shuichi Matsuda. (2022) Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort. Immunological Medicine 45:1, pages 35-44.
Read now
Hiroshi Fujimaki, Akihiro Nakazawa, Motoharu Hirano, Tsuyoshi Takeuchi, Ayahiro Kadowaki, Yoshihiro Kusayama, Manabu Ide, Kenzo Kanai, Yoori Kim, Joji Matsubara, Ken Kumagai & Yutaka Inaba. (2021) Status of fracture risk assessment and osteoporosis treatment in Japanese patients with rheumatoid arthritis. Modern Rheumatology 31:5, pages 987-991.
Read now
Moeko Ochiai, Eiichi Tanaka, Eri Sato, Eisuke Inoue, Mai Abe, Kumiko Saka, Eri Sugano, Naohiro Sugitani, Yoko Higuchi, Rei Yamaguchi, Naoki Sugimoto, Katsunori Ikari, Ayako Nakajima, Hisashi Yamanaka & Masayoshi Harigai. (2021) Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings. Modern Rheumatology 31:4, pages 790-795.
Read now
Shintaro Hirata, Hiroki Kohno, Hirofumi Watanabe, Tadahiro Tokunaga, Yusuke Yoshida, Tomohiro Sugimoto, Sho Mokuda, Keisuke Oda, Takaki Nojima & Eiji Sugiyama. (2021) Tapering and discontinuation of oral glucocorticoids without deterioration of disease status in patients with rheumatoid arthritis under a stable treatment. Modern Rheumatology 31:4, pages 803-808.
Read now
Tsutomu Takeuchi, Maureen Rischmueller, Ricardo Blanco, Ricardo M Xavier, Yukitaka Ueki, Tatsuya Atsumi, Su Chen, Alan Friedman, Aileen L Pangan, Vibeke Strand & Ronald F van Vollenhoven. (2021) Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study. Modern Rheumatology 31:3, pages 534-542.
Read now
Koei Oh, Takefumi Furuya, Katsunori Ikari, Eisuke Inoue, Eiichi Tanaka, Hisashi Yamanaka, Ken Okazaki & Masayoshi Harigai. (2021) Polypharmacy, declined walking speed, bent back, and disability associated with a history of falls in Japanese patients with rheumatoid arthritis: Results from the IORRA cohort study. Modern Rheumatology 31:3, pages 764-767.
Read now
Masanori Nakayama, Takefumi Furuya, Eisuke Inoue, Eiichi Tanaka, Katsunori Ikari, Atsuo Taniguchi, Hisashi Yamanaka & Masayoshi Harigai. (2021) Adherence to denosumab for the treatment of osteoporosis in Japanese patients with rheumatoid arthritis: Results from the IORRA cohort study. Modern Rheumatology 31:2, pages 510-513.
Read now
Koei Oh, Takefumi Furuya, Eisuke Inoue, Eiichi Tanaka, Katsunori Ikari, Atsuo Taniguchi, Hisashi Yamanaka, Ken Okazaki & Masayoshi Harigai. (2021) A simple screening test to assess risk of falls in Japanese patients with rheumatoid arthritis: Results from the IORRA cohort study. Modern Rheumatology 31:2, pages 506-509.
Read now
Haruki Tobimatsu, Katsunori Ikari, Koichiro Yano & Ken Okazaki. (2021) Triple osteotomy for erosive first metatarsal in a patient with rheumatoid arthritis: a case report. Modern Rheumatology Case Reports 5:1, pages 6-10.
Read now

Articles from other publishers (56)

Kenji Takami & Shigeyoshi Tsuji. (2023) Real-world retention rates of biologics in patients with rheumatoid arthritis. Scientific Reports 13:1.
Crossref
Ryutaro Takeda, Takumi Matsumoto, Yasunori Omata, Hiroshi Inui, Shuji Taketomi, Yuichi Nagase, Takuji Nishikawa, Hiroyuki Oka & Sakae Tanaka. (2023) Changes in knee joint destruction patterns among patients with rheumatoid arthritis undergoing total knee arthroplasty in recent decades. Clinical Rheumatology 42:9, pages 2341-2352.
Crossref
Akio Umemoto, Hiromu Ito, Masayuki Azukizawa, Koichi Murata, Masao Tanaka, Takayuki Fujii, Akira Onishi, Hideo Onizawa, Shinichiro Ishie, Akinori Murakami, Kohei Nishitani, Kosaku Murakami, Hiroyuki Yoshitomi, Motomu Hashimoto, Akio Morinobu & Shuichi Matsuda. (2023) How do symptoms of each joint contribute to global pain, disease activity and functional disability in rheumatoid arthritis?—A comprehensive association study using a large cohort. PLOS ONE 18:8, pages e0285227.
Crossref
Ryoko Sakai, Eiichi Tanaka, Eisuke Inoue, Minako Sato, Masaru Tanaka, Katsunori Ikari, Hisashi Yamanaka & Masayoshi Harigai. (2023) Association between patient-reported outcomes and impairments in work and activity in patients with rheumatoid arthritis in clinical remission: A retrospective analysis using the IORRA database. Modern Rheumatology 33:5, pages 899-905.
Crossref
Masayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, Naoto Tamura, Kenta Misaki, Takanori Azuma, Shintaro Hirata, Fuminori Hirano, Yoshinori Taniguchi, Masaki Mitsuhashi, Masahiro Kondo, Motohiro Oribe, Kazutoshi Aoki, Michiaki Kadode, Katsuki Tsuritani & Hisashi Yamanaka. (2023) Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanese real-world observational ‘ORIGAMI’ study . Modern Rheumatology.
Crossref
Shigeki Momohara, Kei Ikeda, Masahiro Tada, Toshiaki Miyamoto, Takanori Mito, Keita Fujimoto, Ayako Shoji, Eriko Wakita & Mitsumasa Kishimoto. (2023) Patient–Physician Communication and Perception of Treatment Goals in Rheumatoid Arthritis: An Online Survey of Patients and Physicians. Rheumatology and Therapy 10:4, pages 917-931.
Crossref
Tomoaki Higuchi, Eiichi Tanaka, Eisuke Inoue, Mai Abe, Kumiko Saka, Eri Sugano, Naohiro Sugitani, Yoko Higuchi, Moeko Ochiai, Rei Yamaguchi, Katsunori Ikari, Hisashi Yamanaka & Masayoshi Harigai. (2023) Evaluation of the Rheumatoid Arthritis Observation of Biologic Therapy risk score in Japanese patients with rheumatoid arthritis starting first biologic disease–modifying antirheumatic drugs: A validation study using the Institute of Rheumatology, Rheumatoid Arthritis cohort data. Modern Rheumatology.
Crossref
Naoki Sugimoto, Eiichi Tanaka, Eisuke Inoue, Mai Abe, Eri Sugano, Naohiro Sugitani, Kumiko Saka, Moeko Ochiai, Yoko Higuchi, Rei Yamaguchi, Katsunori Ikari, Ayako Nakajima, Hisashi Yamanaka & Masayoshi Harigai. (2023) Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort. Modern Rheumatology 33:4, pages 715-722.
Crossref
Masataka Kuwana, Naonobu Sugiyama, Shigeki Momohara, Tatsuya Atsumi, Syuji Takei, Naoto Tamura, Masayoshi Harigai, Takao Fujii, Hiroaki Matsuno, Tsutomu Takeuchi, Kazuhiko Yamamoto, Yoshinari Takasaki, Miki Tanigawa, Yutaka Endo, Tomohiro Hirose, Yosuke Morishima, Noritoshi Yoshii, Tsuneyo Mimori & Michiaki Takagi. (2023) Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance. Modern Rheumatology.
Crossref
Eri Sugano, Eiichi Tanaka, Eisuke Inoue, Suguru Honda, Mai Abe, Kumiko Saka, Naohiro Sugitani, Moeko Ochiai, Rei Yamaguchi, Katsunori Ikari & Masayoshi Harigai. (2023) Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort. Rheumatology.
Crossref
Suguru Honda, Koichiro Yano, Eiichi Tanaka, Katsunori Ikari & Masayoshi Harigai. (2023) Development of a scoring model for the Sharp/van der Heijde score using convolutional neural networks and its clinical application. Rheumatology 62:6, pages 2272-2283.
Crossref
Yumi Nomura, Hajime Ishikawa, Asami Abe, Hiroshi Otani, Satoshi Ito, Yoshio Kaji, Tetsuji Yamamoto, Kiyoshi Nakazono & Akira Murasawa. (2023) More than 20 years’ follow-up of metatarsal neck shortening oblique osteotomy for rheumatoid forefoot deformity. Journal of Orthopaedic Science 28:3, pages 607-613.
Crossref
Takako Miyamae, Eisuke Inoue, Eiichi Tanaka, Tomohiro Kawabe, Katsunori Ikari & Masayoshi Harigai. (2023) Association of disease activity using SDAI and DAS28, but not JADAS-27, with subsequent changes in physical function in adult patients with juvenile idiopathic arthritis. Modern Rheumatology 33:3, pages 588-593.
Crossref
Ryoko Sakai, Eiichi Tanaka, Eisuke Inoue, Minako Sato, Masaru Tanaka, Katsunori Ikari, Hisashi Yamanaka & Masayoshi Harigai. (2023) Subjective symptoms contributing to the quality of life of rheumatoid arthritis patients with clinical remission from the IORRA database. Modern Rheumatology 33:3, pages 496-502.
Crossref
Ayako Tominaga, Katsunori Ikari, Koichiro Yano, Eiichi Tanaka, Eisuke Inoue, Masayoshi Harigai & Ken Okazaki. (2023) Surgical intervention for patients with rheumatoid arthritis is declining except for foot and ankle surgery: A single-centre, 20-year observational cohort study. Modern Rheumatology 33:3, pages 509-516.
Crossref
Saravanan Srinivasan, Subathra Gunasekaran, Sandeep Kumar Mathivanan, Prabhu Jayagopal, Muhammad Attique Khan, Areej Alasiry, Mehrez Marzougui & Anum Masood. (2023) A Framework of Faster CRNN and VGG16-Enhanced Region Proposal Network for Detection and Grade Classification of Knee RA. Diagnostics 13:8, pages 1385.
Crossref
Ichiro Yoshii, Naoya Sawada & Tatsumi Chijiwa. (2022) Associations between clinical metrics of joint deformity, disease duration, disease activity, functional capacity, quality of life, pain, and fatigue in patients with rheumatoid arthritis. Clinical Rheumatology 42:4, pages 1027-1038.
Crossref
Masayoshi Harigai, Takao Fujii, Ryoko Sakai, Ataru Igarashi, Ayako Shoji, Hiroko Yamaguchi, Katsuhiko Iwasaki, Misako Makishima, Amika Yoshida, Norihiro Okada, Katsuhisa Yamashita & Yutaka Kawahito. (2023) Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of data from a Japanese claims database. Modern Rheumatology.
Crossref
Masataka Kuwana, Naoto Tamura, Shinsuke Yasuda, Keishi Fujio, Ayako Shoji, Hiroko Yamaguchi, Katsuhiko Iwasaki, Misako Makishima, Yuichi Kawata, Katsuhisa Yamashita & Ataru Igarashi. (2023) Cost-effectiveness analyses of biologic and targeted synthetic disease-modifying anti-rheumatic diseases in patients with rheumatoid arthritis: Three approaches with a cohort simulation and real-world data. Modern Rheumatology 33:2, pages 302-311.
Crossref
Tommy Harty, Michelle O’Shaughnessy & Sinead Harney. (2023) Therapeutics in rheumatology and the kidney. Rheumatology 62:3, pages 1009-1020.
Crossref
Naohiro Sugitani, Eiichi Tanaka, Eisuke Inoue, Mai Abe, Eri Sugano, Kumiko Saka, Moeko Ochiai, Yoko Higuchi, Rei Yamaguchi, Naoki Sugimoto, Katsunori Ikari, Ayako Nakajima, Hisashi Yamanaka & Masayoshi Harigai. (2023) Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort. Modern Rheumatology.
Crossref
Hisashi Yamanaka, Mitsumasa Kishimoto, Nobuo Nishijima, Katsuhisa Yamashita, Junnosuke Matsushima, Jacqueline O’Brien, Taylor Blachley, Melissa Eliot, Zachary Margolin, Swapna S Dave & Yoshiya Tanaka. (2023) Socioeconomic impact of treatment with biological disease–modifying antirheumatic drugs in Japanese patients with rheumatoid arthritis. Modern Rheumatology.
Crossref
Hiromu Ito, Keiichiro Nishida, Toshihisa Kojima, Isao Matsushita, Masayo Kojima, Shintaro Hirata, Yuko Kaneko, Mitsumasa Kishimoto, Masataka Kohno, Masaaki Mori, Akio Morinobu, Atsuko Murashima, Yohei Seto, Takahiko Sugihara, Eiichi Tanaka, Takeo Nakayama, Hisashi Yamanaka, Yutaka Kawahito & Masayoshi Harigai. (2023) Non-drug and surgical treatment algorithm and recommendations for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication. Modern Rheumatology 33:1, pages 36-45.
Crossref
Tatsuya Atsumi, Eri Asakura, Michio Doi, Ruta Sawant, Isao Kawaguchi, Nobuhito Sasaki & Danny Liew. (2023) Number needed to treat and cost per responder of Janus kinase inhibitors approved for the treatment of moderate-to-severe rheumatoid arthritis in Japan. Modern Rheumatology 33:1, pages 54-63.
Crossref
Haruki Tobimatsu, Katsunori Ikari, Koichiro Yano & Ken Okazaki. (2023) Radiographic factors associated with painful callosities after forefoot surgery in patients with rheumatoid arthritis. Modern Rheumatology 33:1, pages 104-110.
Crossref
Rocío-V. Gamboa-Cárdenas, Manuel-F. Ugarte-Gil, Víctor Pimentel-Quiroz, Cristina Reátegui -Sokolova, Zoila Rodríguez-Bellido, Francisco Zevallos-Miranda, Mariela Medina-Chinchón, José Alfaro-Lozano, Erika Noriega-Zapata, J. Mariano Cucho-Venegas, Risto Perich-Campos, César Pastor-Asurza & Graciela S. Alarcón. (2022) Predictors of Remission and Low Disease Activity in Rheumatoid Arthritis Patients. JCR: Journal of Clinical Rheumatology 28:8, pages 390-396.
Crossref
Ryutaro Takeda, Takumi Matsumoto, Yuji Maenohara, Yasunori Omata, Hiroshi Inui, Yuichi Nagase, Takuji Nishikawa & Sakae Tanaka. (2022) Increasing trend of radiographic features of knee osteoarthritis in rheumatoid arthritis patients before total knee arthroplasty. Scientific Reports 12:1.
Crossref
Cong Chen, Peng Wang, Ruo-Di Zhang, Yang Fang, Ling-Qiong Jiang, Xi Fang, Yan Zhao, De-Guang Wang, Jing Ni & Hai-Feng Pan. (2022) Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases. Autoimmunity Reviews 21:12, pages 103210.
Crossref
Eiichi Tanaka, Eisuke Inoue, Ayako Shoji, Jonas Nilsson, Christos Papagiannopoulos, Devender Dhanda, Yuri Yoshizawa, Mai Abe, Kumiko Saka, Eri Sugano, Naohiro Sugitani, Moeko Ochiai, Rei Yamaguchi, Katsunori Ikari, Hisashi Yamanaka & Masayoshi Harigai. (2022) Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data. PLOS ONE 17:11, pages e0277566.
Crossref
Eiichi Tanaka, Eisuke Inoue, Mai Abe, Kumiko Saka, Eri Sugano, Moeko Ochiai, Rei Yamaguchi, Katsunori Ikari, Hisashi Yamanaka & Masayoshi Harigai. (2022) Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort. Modern Rheumatology 32:6, pages 1193-1195.
Crossref
健太郎 松元, 彰 前山, 裕太郎 山﨑, 大嘉 小田, 邦秀 村岡, 友宣 萩尾 & 卓明 山本. (2022) 関節リウマチに対するバリシチニブの治療成績. Orthopedics & Traumatology 71:4, pages 686-689.
Crossref
Naoto Tamura, Takanori Azuma, Kenta Misaki, Rei Yamaguchi, Fuminori Hirano, Eiji Sugiyama, Daisuke Kanai, Yohko Murakawa, Motohiro Oribe, Takahito Kimata, Kazutoshi Aoki, Tomoko Sugiura, Koji Takasugi, Yuya Takakubo, Yasuyuki Tomita, Takeo Isozaki, Toshihiro Nanki, Naooki Katsuyama, Takanori Kuroiwa, Hideto Oshikawa, Motohide Kaneko, Hiroshi Fujinaga, Kiwamu Saito, Eiichi Tanaka, Eisuke Inoue, Yuri Yoshizawa, Shigeru Matsumoto, Hisashi Yamanaka & Masayoshi Harigai. (2022) Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study). Modern Rheumatology 32:5, pages 846-856.
Crossref
Tomoaki Higuchi, Eiichi Tanaka, Eisuke Inoue, Mai Abe, Kumiko Saka, Eri Sugano, Naohiro Sugitani, Yoko Higuchi, Moeko Ochiai, Rei Yamaguchi, Naoki Sugimoto, Katsunori Ikari, Hisashi Yamanaka & Masayoshi Harigai. (2022) Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohort. Modern Rheumatology 32:5, pages 875-884.
Crossref
Eri Sugano, Eiichi Tanaka, Eisuke Inoue, Ryoko Sakai, Mai Abe, Kumiko Saka, Naohiro Sugitani, Moeko Ochiai, Rei Yamaguchi, Yoko Higuchi, Naoki Sugimoto, Katsunori Ikari, Ayako Nakajima, Hisashi Yamanaka & Masayoshi Harigai. (2022) Differences in patients’ population and efficacy/effectiveness of biologic disease–modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis – using the IORRA cohort. Modern Rheumatology 32:4, pages 675-685.
Crossref
Noritaka Saeki, Kazuki Inoue, Maky Ideta-Otsuka, Kunihiko Watamori, Shinichi Mizuki, Katsuto Takenaka, Katsuhide Igarashi, Hiromasa Miura, Shu Takeda & Yuuki Imai. (2022) Epigenetic regulator UHRF1 orchestrates proinflammatory gene expression in rheumatoid arthritis in a suppressive manner. Journal of Clinical Investigation 132:11.
Crossref
Suguru Honda, Katsunori Ikari, Koichiro Yano, Chikashi Terao, Eiichi Tanaka, Masayoshi Harigai & Yuta Kochi. (2022) Association of Polygenic Risk Scores With Radiographic Progression in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology 74:5, pages 791-800.
Crossref
Rei Yamaguchi, Eiichi Tanaka, Ayako Nakajima, Eisuke Inoue, Mai Abe, Eri Sugano, Naohiro Sugitani, Kumiko Saka, Moeko Ochiai, Yoko Higuchi, Naoki Sugimoto, Katsunori Ikari, Hisashi Yamanaka & Masayoshi Harigai. (2022) Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids. Modern Rheumatology 32:3, pages 522-527.
Crossref
Victor M Castro, Vivian Gainer, Nich Wattanasin, Barbara Benoit, Andrew Cagan, Bhaswati Ghosh, Sergey Goryachev, Reeta Metta, Heekyong Park, David Wang, Michael Mendis, Martin Rees, Christopher Herrick & Shawn N Murphy. (2022) The Mass General Brigham Biobank Portal: an i2b2-based data repository linking disparate and high-dimensional patient data to support multimodal analytics. Journal of the American Medical Informatics Association 29:4, pages 643-651.
Crossref
Yoshiya Tanaka, Tsukasa Matsubara, Tatsuya Atsumi, Koichi Amano, Naoki Ishiguro, Eiji Sugiyama, Kunihiro Yamaoka, Bernard G Combe, Alan J Kivitz, Sang-Cheol Bae, Edward C Keystone, Peter Nash, Franziska Matzkies, Beatrix Bartok, Alena Pechonkina, Akira Kondo, Lei Ye, Ying Guo, Chantal Tasset, John S Sundy & Tsutomu Takeuchi. (2022) Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1). Modern Rheumatology 32:2, pages 263-272.
Crossref
Tatsuya Atsumi, Yoshiya Tanaka, Tsukasa Matsubara, Koichi Amano, Naoki Ishiguro, Eiji Sugiyama, Kunihiro Yamaoka, René Westhovens, Daniel W.T Ching, Osvaldo Daniel Messina, Gerd R Burmester, Beatrix Bartok, Alena Pechonkina, Akira Kondo, Zhaoyu Yin, Ying Guo, Chantal Tasset, John S Sundy & Tsutomu Takeuchi. (2022) Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3). Modern Rheumatology 32:2, pages 273-283.
Crossref
Hiromu Ito, Koichi Murata, Yasumori Sobue, Toshihisa Kojima, Keiichiro Nishida, Isao Matsushita, Yutaka Kawahito, Masayo Kojima, Shintaro Hirata, Yuko Kaneko, Mitsumasa Kishimoto, Masataka Kohno, Masaaki Mori, Akio Morinobu, Atsuko Murashima, Yohei Seto, Takahiko Sugihara, Eiichi Tanaka, Takeo Nakayama & Masayoshi Harigai. (2022) Comprehensive risk analysis of postoperative complications in patients with rheumatoid arthritis for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis. Modern Rheumatology 32:2, pages 296-306.
Crossref
Takefumi Furuya, Koei Oh, Katsunori Ikari, Eisuke Inoue, Eiichi Tanaka, Hisashi Yamanaka & Masayoshi Harigai. (2021) Factors associated with frailty in Japanese patients with rheumatoid arthritis: results from the Institute of Rheumatology Rheumatoid Arthritis cohort study. Clinical Rheumatology 41:2, pages 405-410.
Crossref
Atsushi Hirata, Ryosuke Ota, Takeo Hata, Takeshi Hamada, Masami Nishihara, Kazuhisa Uchiyama & Takahiro Katsumata. (2021) Prescribing Trends of Biologic Disease-Modifying Anti-rheumatic Drugs Using a Claims Database from 6 Million People in Japan. Clinical Drug Investigation 41:11, pages 967-974.
Crossref
Yuya Takakubo, Yoshihiro Wanezaki, Hiroharu Oki, Yasushi Naganuma, Junichiro Shibuya, Ryusuke Honma, Akemi Suzuki, Hiroshi Satake & Michiaki Takagi. (2021) Forefoot Deformities in Patients with Rheumatoid Arthritis: Mid- to Long-Term Result of Joint-Preserving Surgery in Comparison with Resection Arthroplasty. International Journal of Environmental Research and Public Health 18:21, pages 11257.
Crossref
Mitsumasa Kishimoto, Fumiko Yamairi, Noriko Sato, Jun Kobayashi, Saori Yamauchi & Tomohisa Iwasaki. (2021) Patient Preference for Treatment Mode of Biologics in Rheumatoid Arthritis: A 2020 Web-based Survey in Japan. Rheumatology and Therapy 8:3, pages 1095-1111.
Crossref
Yoshiya Tanaka, Sang-Cheol Bae, Damon Bass, Paula Curtis, Myron Chu, Kathleen DeRose, Beulah Ji, Regina Kurrasch, Jenny Lowe, Paige Meizlik & David A Roth. (2021) Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea. RMD Open 7:2, pages e001629.
Crossref
Katherine W Cook, Wei Xue, Peter Symonds, Ian Daniels, Mohamed Gijon, David Boocock, Clare Coveney, Amanda K Miles, Sabaria Shah, Suha Atabani, Ruhul H Choudhury, Poonam Vaghela, Daisy Weston, Rachael L Metheringham, Victoria A Brentville & Lindy G Durrant. (2021) Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy. Journal for ImmunoTherapy of Cancer 9:7, pages e001910.
Crossref
Philip G. Conaghan, Eduardo Mysler, Yoshiya Tanaka, Barbara Da Silva-Tillmann, Tim Shaw, John Liu, Ryan Ferguson, Jeffrey V. Enejosa, Stanley Cohen, Peter Nash, William Rigby & Gerd Burmester. (2021) Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program. Drug Safety 44:5, pages 515-530.
Crossref
Koichiro Yano, Katsunori Ikari, Haruki Tobimatsu, Ayako Tominaga & Ken Okazaki. (2021) Joint-Preserving Surgery for Forefoot Deformities in Patients with Rheumatoid Arthritis: A Literature Review. International Journal of Environmental Research and Public Health 18:8, pages 4093.
Crossref
Koichiro Yano, Katsunori Ikari, Haruki Tobimatsu & Ken Okazaki. (2021) Patient-Reported and Radiographic Outcomes of Joint-Preserving Surgery for Rheumatoid Forefoot Deformities. Journal of Bone and Joint Surgery 103:6, pages 506-516.
Crossref
Xinping Tian, Mengtao Li & Xiaofeng Zeng. (2021) The current status and challenges in the diagnosis and treatment of rheumatoid arthritis in China: An annual report of 2019. Rheumatology and Immunology Research 2:1, pages 49-56.
Crossref
Chihiro Nakagawa, Satoshi Yokoyama, Kouichi Hosomi & Mitsutaka Takada. (2021) Repurposing haloperidol for the treatment of rheumatoid arthritis: an integrative approach using data mining techniques. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110470.
Crossref
Takeshi Kashiwagura, Hiroshi Aonuma, Tetsuya Kawano, Naohisa Miyakoshi & Yoichi Shimada. (2020) Cohort Study of Rheumatoid Arthritis in Japanわが国におけるコホート研究. The Japanese Journal of Rehabilitation Medicine 57:11, pages 1054-1061.
Crossref
Yuya Shirai, Suguru Honda, Katsunori Ikari, Masahiro Kanai, Yoshito Takeda, Yoichiro Kamatani, Takayuki Morisaki, Eiichi Tanaka, Atsushi Kumanogoh, Masayoshi Harigai & Yukinori Okada. (2020) Association of the RPA3-UMAD1 locus with interstitial lung diseases complicated with rheumatoid arthritis in Japanese . Annals of the Rheumatic Diseases 79:10, pages 1305-1309.
Crossref
Masanori Nakayama, Takefumi Furuya, Eisuke Inoue, Eiichi Tanaka, Katsunori Ikari, Atsuo Taniguchi, Hisahi Yamanaka & Masayoshi Harigai. (2020) Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study. Osteoporosis and Sarcopenia 6:2, pages 82-87.
Crossref
Naoto Yokogawa, Kota Shimada, Shoji Sugii, Akiko Komiya, Toshihiro Matsui, Jinju Nishino & Shigeto Tohma. (2020) A Proposal to Standardize Low Disease Activity Criteria in Rheumatoid Arthritis Based on the Outcome Measures in Rheumatology Minimal Disease Activity Definition. ACR Open Rheumatology 2:5, pages 301-306.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.